BioAmber

BioAmber COO Fabrice Orecchioni named President

BioAmber Inc. (NYSE: BIOA) announced today that Jean-Francois Huc has resigned as President and CEO and Fabrice Orecchioni, the company's COO, has been named President, effective immediately. In his role as COO over the past four years,...

Kennet Brysting appointed General Manager, Gilead Canada

Kennet Brysting has been appointed General Manager of Gilead Sciences Canada, Inc., assuming leadership of Gilead's sixth-largest market. The former General Manager of Gilead Nordics (Sweden, Norway, Denmark, Finland and Iceland), Kennet Brysting also joins...
Nativis

Nativis Rounds Out Board of Directors with Appointment of Dr. Una Ryan

Nativis Inc., a clinical stage life science bio-electronic company developing non-invasive, safe and highly effective treatments for cancers and other serious diseases, today announced that Dr. Una Ryan has been appointed to its board...
NObilis

Nobilis Health Corp. appoints David Young as CFO

Nobilis Health Corp. today announced the appointment of Mr. David Young as its Chief Financial Officer.  Mr. Young brings to Nobilis extensive Fortune 500 company executive experience in corporate finance, financial planning, and cost...
Sally Waterman, COO and Angus Hone, CFO

Medherant expands management team with appointment of Sally Waterman, COO and Angus Hone, CFO

  Medherant Ltd, a University of Warwick spin-out company developing a next-generation transdermal drug delivery patch technology, is pleased to announce the appointment of two new senior executives, Sally Waterman and Angus Hone. These appointments...
3d4medical

3D4Medical Announces the Appointment of Top Academics to Its Academic Review Board

3D4Medical, the world’s leading developer of ground-breaking 3D medical technology applications, is delighted to announce the appointment of its Academic Review Board. Comprising esteemed leaders from the international academic community, the board will help...
aelix therapeutics DR. IAN MCGOWAN

Aelix Therapeutics Appoints Dr. Ian McGowan As Chief Medical Officer

HIV expert will support company in advancing therapeutic HIV vaccine to clinical proof-of-concept Barcelona, Spain, April 5, 2017 - Aelix Therapeutics, a drug development company specialized in the discovery and development of immunotherapies against...
biosys health

Biosys Appoints Axel Wiest to Board of Directors

Biosys Health UK Limited, a clinical-stage microbiome company dedicated to the development of targeted oral immune therapies that modulate the gut microbiome, initially focused on the treatment of C.difficile infection (“CDI”), is pleased to...
Asit biotech

Asit Biotech Appoints Gerd Zettlmeissl

Asit biotech: Expertise in vaccines Belgian clinical-stage immunotherapy developer  Asit biotech has appointed Gerd Zettlmeissl as its new Chairman of the Board. Zettlmeissl has been independent director of the company since 2011.   Before joining Asit biotech,...
medherant website screenshot

Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products Based on its Revolutionary...

Coventry, UK, 6th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a novel transdermal drug delivery patch technology, is pleased to announce the appointment of Sheryl Caswell as Head...